1. Home
  2. Browse
  3. Diabetes & Endocrinology
  4. Diabetes
  5. Treatment
  6. SGLT2 Inhibitors

SGLT2 Inhibitors

46 - 60 of 71 Results
Sort Results:
Patient Education: Diabetes and Fasting May 2016
Patient Education: Have Diabetes? Take Care of Your Feet! April 2016
Other: SGLT2 Inhibitors and Risk of Ketoacidosis and Serious UTIs February 2016
Article: Caution about ketoacidosis, UTIs, and other serious ADRs with the SGLT2s February 2016
Article: Consider Canaglifozin As A Cause of Fractures December 2015
Commentary: Canagliflozin (Invokana, Invokamet) Bone Fracture Risk December 2015
PL Voices: Cardiovascular Outcomes with Empagliflozin (Jardiance) November 2015
Commentary: Empagliflozin and Cardiovascular Disease November 2015
Article: Don't be too Quick to Jump on the Jardiance (empagliflozin) Bandwagon November 2015
Chart: How to Switch Insulin Products November 2015
Other: Adverse Event Reporting Program July 2015
Other: SGLT2 Inhibitors (Flozins) and Ketoacidosis/Urinary Tract Infections (Dec 2015) July 2015
Article: Treat Flozin Ketoacidosis With Your Diabetic Ketoacidosis Protocol July 2015
Article: Double Check Diabetes Regimens for Duplicationsat Discharge June 2015
PL Voices: What’s New in the Management of Hyperglycemia in Type 2 Diabetes? June 2015